Hull Andrew
- SEC CIK
- 0001818252
No open-market purchases or sales filed in the past year.
Current role at each company
- INM InMed Pharmaceuticals Inc.Directoras of Dec 19, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hull Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2024 (view filing)1:38 PM ET | Feb 21 | 1 day | Hull AndrewDirector | PPurchase | +37.5K | $0.39 | +$14.6K | +4,947.2%38.3K after |